HF
NYMX

HRT Financial’s Nymox Pharmaceutical Corp NYMX Stock Holding History

HRT Financial’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-114,635
Closed -$236K – 4351
2021
Q3 		$236K Sell
114,635
-5,531
-5% -$9.8K ﹤0.01% 2573
2021
Q2 		$189K Buy
+120,166
New +$223K ﹤0.01% 2415

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

HRT Financial's NYMX Position: Q4 2021 in Review

HRT Financial sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2021, closing a stake of 114,635 shares — an estimated $236K sold.

HRT Financial first reported a position in NYMX in Q2 2021 and held it in 2 quarters. The position peaked at $236K in Q3 2021. 43 funds tracked by Wall St. Rank hold NYMX as of Q4 2021.

  • HRT Financial reported no remaining Nymox Pharmaceutical Corp position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 114,635 Nymox Pharmaceutical Corp shares in Q4 2021, an estimated $236K.
  • HRT Financial first reported a position in Nymox Pharmaceutical Corp in Q2 2021 and held it in 2 quarters.
  • HRT Financial's Nymox Pharmaceutical Corp position peaked at $236K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.